Bilateral Erector Spinae Plane Block (ESPB) in Laparoscopic Cholecystectomies
Primary Purpose
Pain, Postoperative, Pain Syndrome, Pain, Acute
Status
Completed
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Group Dexmedetomidine
Group Ropivacaine
Group Control
Sponsored by
About this trial
This is an interventional prevention trial for Pain, Postoperative
Eligibility Criteria
Inclusion Criteria:
- ASA I, II
- Laparoscopic cholecystectomy
- Elective surgery
Exclusion Criteria:
- Patient refusal
- Coagulation disorders
- Known allergies to local anesthetics
- Other contraindications to regional anesthesia
- Infection or anatomic anomalies on injection site
- Uncontrolled hypertension
- Severe liver or kidney disease
- Pregnancy
- Known depression or psychiatric disorders, dementia
- Drug or alcohol abuse
- Inadequate command of Greek language
Sites / Locations
- George Papanikolaou, General Hospital of Thessaloniki
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Placebo Comparator
Arm Label
Group Dexmedetomidine
Group Ropivacaine
Group Control
Arm Description
Ropivacaine plus dexmedetomidine group - Preoperative bilateral erector spinae plane block with ropivacaine 0,375% (40 ml) plus dexmedetomidine 1 mcg/kg
Plain ropivacaine group - Preoperative bilateral erector spinae plane block with ropivacaine 0,375% (40 ml)
Control group - Preoperative bilateral erector spinae plane block with N/S 0,9% (40 ml)
Outcomes
Primary Outcome Measures
pain score 3 hours postoperatively
pain score by the use of Numeric Rating Scale (NRS) 3 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
pain score 6 hours postoperatively
pain score by the use of Numeric Rating Scale (NRS) 6 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
pain score 12 hours postoperatively
pain score by the use of Numeric Rating Scale (NRS) 12 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
pain score 24 hours postoperatively
pain score by the use of Numeric Rating Scale (NRS) 24 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
pain score on arrival to Post-Anesthesia Care Unit (PACU)
pain score by the use of Numeric Rating Scale (NRS) on arrival to PACU, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
pain score at discharge from Post-Anesthesia Care Unit (PACU), ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
pain score by the use of Numeric Rating Scale (NRS) at discharge from PACU
Secondary Outcome Measures
morphine consumption
morphine consumption through patient-controlled analgesia device for 24 hours postoperatively
satisfaction from postoperative analgesia
satisfaction from postoperative analgesia on a six-point Likert scale with 1 marked as minimal satisfaction and 6 as maximal satisfaction
mobilization time
time at which the patient mobilizes after surgery
hospitalization time
duration of hospital stay after surgery in days
intraoperative dose of remifentanil infusion (μg kg-1)
dose of required remifentanil intraoperatively to maintain systolic arterial blood pressure within the 20% of baseline value
Erector Spinae Plane Block-related complications
block-related complications at the site of the local anesthetic injection
Post Anesthesia Care Unit (PACU) duration of stay
duration of patient stay at PACU
Full Information
NCT ID
NCT04587973
First Posted
October 8, 2020
Last Updated
July 10, 2022
Sponsor
Aretaieion University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04587973
Brief Title
Bilateral Erector Spinae Plane Block (ESPB) in Laparoscopic Cholecystectomies
Official Title
The Effectiveness of Bilateral Erector Spinae Plane Block (ESPB) in Laparoscopic Cholecystectomies. A Randomized, Controlled, Double Blind, Prospective, Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
June 1, 2020 (Actual)
Primary Completion Date
April 1, 2022 (Actual)
Study Completion Date
April 1, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aretaieion University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The aim of the trial is to study the efficacy of bilateral Erector Spinae Plane Block (ESPB) in managing perioperative pain in patients who undergo elective laparoscopic cholecystectomy
Detailed Description
Laparoscopic cholecystectomy is one of the most common performed procedures of general surgery. Although it is performed with minimally invasive techniques, postoperative pain can be moderate to severe, requiring administration of large doses of opioids perioperatively in combination with other categories of analgesics in order to be relieved. Modern anesthesiology practices tend to limit the opioids administered to patients due to a variety of complications observed, specifically in certain populations (obese, elderly) and also due to the opioid crisis appearance in United States and in many European countries. As such, multimodal analgesia and opioid limitation is the cornerstone of modern perioperative pain management.
Peripheral nerve blocks and especially trunk blocks can play a significant role when confronting perioperative pain. Erector spinae Plane Block (ESPB) is a novel trunk block first described in order to relieve thoracic neuropathic pain. Since then, it was performed by anesthesiologists for chronic pain, acute post traumatic pain and in a wide variety of surgical procedures for postoperative analgesia.
There are no trials that study the efficacy of adding dexmedetomidine as an adjuvant to the local anesthetic in order to ameliorate the quality and extend the duration of the Erector Spinae Plane Block.
This trial is a randomized, controlled, double - blind, prospective trial, aiming at assessing the efficacy of bilateral Erector Spinae Plane Block (ESPB) in managing perioperative pain in patients who undergo elective laparoscopic cholecystectomy. In this trial, 60 patients (men and women), aged 18 to 70 years old that will undergo laparoscopic cholecystectomy which will be performed by the same experienced, surgical team, will be recruited.
Patients will be randomized into three groups, Group D (Ropivacaine plus dexmedetomidine group), Group R (Plain Ropivacaine group) and Group C (Control group).
The solutions that will be administered during the performance of ESPB, will be prepared by an independent anesthesiologist. The ultrasound image during the performance of ESPB, as well as the complications that may arise after the performance of the block, will be recorded.
The age, sex, American Society of Anesthesiologists (ASA) classification, height and weight of the participants, will be recorded.
After the induction of general anesthesia [propofol (2-3 mg/kg), fentanyl (2-3 γ/kg), rocuronium (0,6 mg/kg)], general anesthesia will be maintained with desflurane titration. In all patients, remifentanil infusion will be titrated in order to achieve intraoperative analgesia (Systolic Arterial Blood Pressure within the 20% of Baseline Systolic Blood Pressure). In all patients Paracetamol 1000 mg and Tramadol 100 mg will be administered, 30 minutes before the end of surgery. During surgery, vital signs, remifentanil infusion or other drugs that will be administered, will be recorded. At the end of surgery, Train of Four stimulation will be performed and in the presence of remaining neuromuscular blockade, sugammadex will be administered in the proper doses.
In all patients, post - operative analgesia will be offered with a Patient controlled Analgesia (PCA) pump, containing morphine. Lock - out period will be 10 minutes and the morphine dose will be 20 mcg/kg, without continuous infusion.
The duration of stay of the patient in Post Anesthesia Care Unit (PACU), will be recorded as well as the Aldrete Score and the vital signs the moment the patient leaves the PACU.
Postoperative pain will be recorded at arrival and discharge of the patient from the PACU, as well as 3, 6, 12 and 24 hours after the end of surgery, according to NRS pain scale. All patients will receive Paracetamol 1000 mg x 3 (iv) at the surgical ward.
Post - operative nausea and vomiting, morphine consumption and the vital signs of the patients will be recorded 3, 6, 12and 24 hours after surgery. The mobilization time, hospitalization time, as well as the satisfaction score of the patient in a scale from 1 to 6, 24 hours after the end of surgery will be recorded.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative, Pain Syndrome, Pain, Acute, Anesthesia, Cholecystectomy, Erector Spinae Plane Block
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group Dexmedetomidine
Arm Type
Active Comparator
Arm Description
Ropivacaine plus dexmedetomidine group - Preoperative bilateral erector spinae plane block with ropivacaine 0,375% (40 ml) plus dexmedetomidine 1 mcg/kg
Arm Title
Group Ropivacaine
Arm Type
Active Comparator
Arm Description
Plain ropivacaine group - Preoperative bilateral erector spinae plane block with ropivacaine 0,375% (40 ml)
Arm Title
Group Control
Arm Type
Placebo Comparator
Arm Description
Control group - Preoperative bilateral erector spinae plane block with N/S 0,9% (40 ml)
Intervention Type
Procedure
Intervention Name(s)
Group Dexmedetomidine
Intervention Description
Ropivacaine plus dexmedetomidine group
Intervention Type
Procedure
Intervention Name(s)
Group Ropivacaine
Intervention Description
Plain ropivacaine group
Intervention Type
Procedure
Intervention Name(s)
Group Control
Intervention Description
Control group
Primary Outcome Measure Information:
Title
pain score 3 hours postoperatively
Description
pain score by the use of Numeric Rating Scale (NRS) 3 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
Time Frame
3 hours after surgery
Title
pain score 6 hours postoperatively
Description
pain score by the use of Numeric Rating Scale (NRS) 6 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
Time Frame
6 hours after surgery
Title
pain score 12 hours postoperatively
Description
pain score by the use of Numeric Rating Scale (NRS) 12 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
Time Frame
12 hours after surgery
Title
pain score 24 hours postoperatively
Description
pain score by the use of Numeric Rating Scale (NRS) 24 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
Time Frame
24 hours after surgery
Title
pain score on arrival to Post-Anesthesia Care Unit (PACU)
Description
pain score by the use of Numeric Rating Scale (NRS) on arrival to PACU, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
Time Frame
immediately postoperatively
Title
pain score at discharge from Post-Anesthesia Care Unit (PACU), ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
Description
pain score by the use of Numeric Rating Scale (NRS) at discharge from PACU
Time Frame
immediately postoperatively
Secondary Outcome Measure Information:
Title
morphine consumption
Description
morphine consumption through patient-controlled analgesia device for 24 hours postoperatively
Time Frame
24 hours postoperatively
Title
satisfaction from postoperative analgesia
Description
satisfaction from postoperative analgesia on a six-point Likert scale with 1 marked as minimal satisfaction and 6 as maximal satisfaction
Time Frame
24 hours postoperatively
Title
mobilization time
Description
time at which the patient mobilizes after surgery
Time Frame
24 hours postoperatively
Title
hospitalization time
Description
duration of hospital stay after surgery in days
Time Frame
72 hours postoperatively
Title
intraoperative dose of remifentanil infusion (μg kg-1)
Description
dose of required remifentanil intraoperatively to maintain systolic arterial blood pressure within the 20% of baseline value
Time Frame
intraoperatively
Title
Erector Spinae Plane Block-related complications
Description
block-related complications at the site of the local anesthetic injection
Time Frame
48 hours postoperatively
Title
Post Anesthesia Care Unit (PACU) duration of stay
Description
duration of patient stay at PACU
Time Frame
immediately postoperatively
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
ASA I, II
Laparoscopic cholecystectomy
Elective surgery
Exclusion Criteria:
Patient refusal
Coagulation disorders
Known allergies to local anesthetics
Other contraindications to regional anesthesia
Infection or anatomic anomalies on injection site
Uncontrolled hypertension
Severe liver or kidney disease
Pregnancy
Known depression or psychiatric disorders, dementia
Drug or alcohol abuse
Inadequate command of Greek language
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kassiani Theodoraki, PhD, DESA
Organizational Affiliation
Aretaieion University Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
George Papanikolaou, General Hospital of Thessaloniki
City
Thessaloníki
ZIP/Postal Code
57010
Country
Greece
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
32843804
Citation
Ibrahim M. Erector Spinae Plane Block in Laparoscopic Cholecystectomy, Is There a Difference? A Randomized Controlled Trial. Anesth Essays Res. 2020 Jan-Mar;14(1):119-126. doi: 10.4103/aer.AER_144_19. Epub 2020 Feb 3.
Results Reference
background
PubMed Identifier
32563073
Citation
Herman JA, Urits I, Kaye AD, Urman RD, Viswanath O. Erector Spinae Plane Block (ESPB) or Quadratus Lumborum Block (QLB-II) for laparoscopic cholecystectomy: Impact on postoperative analgesia. J Clin Anesth. 2020 Nov;66:109958. doi: 10.1016/j.jclinane.2020.109958. Epub 2020 Jun 17. No abstract available.
Results Reference
background
PubMed Identifier
32439926
Citation
Kwon HM, Kim DH, Jeong SM, Choi KT, Park S, Kwon HJ, Lee JH. Does Erector Spinae Plane Block Have a Visceral Analgesic Effect?: A Randomized Controlled Trial. Sci Rep. 2020 May 21;10(1):8389. doi: 10.1038/s41598-020-65172-0.
Results Reference
background
PubMed Identifier
32023174
Citation
Peker K, Akcaboy ZN, Aydin G, Gencay I, Sahin AT, Kocak YF, Peker SA. The Effect of Erector Spinae Plane Block on Laparoscopic Cholecystectomy Anesthesia: Analysis of Opioid Consumption, Sevoflurane Consumption, and Cost. J Laparoendosc Adv Surg Tech A. 2020 Jul;30(7):725-729. doi: 10.1089/lap.2019.0809. Epub 2020 Feb 5.
Results Reference
background
PubMed Identifier
31862217
Citation
Aygun H, Kavrut Ozturk N, Pamukcu AS, Inal A, Kiziloglu I, Thomas DT, Tulgar S, Nart A. Comparison of ultrasound guided Erector Spinae Plane Block and quadratus lumborum block for postoperative analgesia in laparoscopic cholecystectomy patients; a prospective randomized study. J Clin Anesth. 2020 Jun;62:109696. doi: 10.1016/j.jclinane.2019.109696. Epub 2019 Dec 18.
Results Reference
background
PubMed Identifier
30590914
Citation
Raft J, Chin KJ, Gobert Q, Richebe P, Brulotte V. Defining the optimal analgesic strategy for erector spinae plane (ESP) blocks in unanticipated open cholecystectomy. Korean J Anesthesiol. 2019 Oct;72(5):504-505. doi: 10.4097/kja.d.18.00350. Epub 2018 Dec 28. No abstract available.
Results Reference
background
PubMed Identifier
36288585
Citation
Sifaki F, Mantzoros I, Koraki E, Bagntasarian S, Christidis P, Theodoraki K. The Effect of Ultrasound-guided Bilateral Erector Spinae Plane Block With and Without Dexmedetomidine on Intraoperative and Postoperative Pain in Laparoscopic Cholecystectomies: A Randomized, Controlled, Double-blind, Prospective Trial. Pain Physician. 2022 Oct;25(7):E999-E1008.
Results Reference
derived
Learn more about this trial
Bilateral Erector Spinae Plane Block (ESPB) in Laparoscopic Cholecystectomies
We'll reach out to this number within 24 hrs